Page last updated: 2024-08-22

calcium pyrophosphate and Disease Exacerbation

calcium pyrophosphate has been researched along with Disease Exacerbation in 14 studies

Research

Studies (14)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (14.29)18.2507
2000's8 (57.14)29.6817
2010's4 (28.57)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Aringer, M; Tausche, AK1
Cullen, N; Ferrero, A; Goldberg, A; Lomax, A; Singh, D1
Wener, MH1
Pritzker, KP1
Oliviero, F; Punzi, L; Scanu, A1
Andracco, R; Cimmino, MA; Ferrone, C1
Dalbeth, N; Haskard, DO1
McCarthy, GM1
Kalya, S; Rosenthal, AK1
Lioté, F; Liu-Bryan, R1
Dudler, J; Gerster, JC; Kern, J; So, AK; Varisco, PA1
Announ, N; Guerne, PA1
Doherty, M; Jones, A; Ledingham, J; Regan, M1
Ishii, Y; Sasaki, S1

Reviews

6 review(s) available for calcium pyrophosphate and Disease Exacerbation

ArticleYear
[Chondrocalcinosis due to calcium pyrophosphate deposition (CPPD). From incidental radiographic findings to CPPD crystal arthritis].
    Zeitschrift fur Rheumatologie, 2014, Volume: 73, Issue:4

    Topics: Arthrography; Calcium Pyrophosphate; Cartilage, Articular; Chondrocalcinosis; Crystallization; Diagnosis, Differential; Disease Progression; Humans; Incidental Findings; Joints; Synovial Fluid; Ultrasonography

2014
Counterpoint: Hydroxyapatite crystal deposition is not intimately involved in the pathogenesis and progression of human osteoarthritis.
    Current rheumatology reports, 2009, Volume: 11, Issue:2

    Topics: Animals; Arthroplasty; Calcium Pyrophosphate; Cartilage, Articular; Cells, Cultured; Chondrocytes; Crystallization; Disease Models, Animal; Disease Progression; Durapatite; Fibroblasts; Humans; Osteoarthritis, Hip; Osteoarthritis, Knee; Synovial Membrane

2009
Metabolism of crystals within the joint.
    Reumatismo, 2012, Jan-19, Volume: 63, Issue:4

    Topics: Arthritis, Gouty; Biomarkers; Calcium Phosphates; Calcium Pyrophosphate; Chondrocalcinosis; Chondrocytes; Crystallization; Disease Progression; Gout; Humans; Hyperuricemia; Signal Transduction; Synovial Membrane; Uric Acid

2012
Calcium pyrophosphate deposition disease: clinical manifestations.
    Reumatismo, 2012, Jan-19, Volume: 63, Issue:4

    Topics: Arthrography; Biomarkers; Calcium Pyrophosphate; Chondrocalcinosis; Diagnosis, Differential; Disease Progression; Gout Suppressants; Humans; Joints; Ligaments; Osteoarthritis; Risk Factors; Spine; Synovial Fluid; Tendons

2012
Extracellular matrix changes regulate calcium crystal formation in articular cartilage.
    Current opinion in rheumatology, 2005, Volume: 17, Issue:3

    Topics: Calcium Phosphates; Calcium Pyrophosphate; Cartilage, Articular; Disease Progression; Extracellular Matrix; Humans; Osteoarthritis

2005
Monosodium urate and calcium pyrophosphate dihydrate (CPPD) crystals, inflammation, and cellular signaling.
    Joint bone spine, 2005, Volume: 72, Issue:4

    Topics: Animals; Arthritis; Calcium Pyrophosphate; Disease Progression; Humans; Signal Transduction; Synovial Membrane; Uric Acid

2005

Other Studies

8 other study(ies) available for calcium pyrophosphate and Disease Exacerbation

ArticleYear
Destructive pseudo-neuroarthropathy associated with calcium pyrophosphate deposition.
    Foot & ankle international, 2015, Volume: 36, Issue:4

    Topics: Adult; Aged; Ankle Joint; Arthropathy, Neurogenic; Calcium Pyrophosphate; Chondrocalcinosis; Cohort Studies; Combined Modality Therapy; Disease Progression; Female; Follow-Up Studies; Humans; Male; Metatarsophalangeal Joint; Middle Aged; Radiography; Retrospective Studies; Risk Assessment; Severity of Illness Index; Tarsal Joints; Treatment Outcome

2015
Destructive temporomandibular joint disease: also consider tophaceous voracious (hydroxy)apatite.
    The Journal of rheumatology, 2009, Volume: 36, Issue:2

    Topics: Calcium Pyrophosphate; Chondrocalcinosis; Disease Progression; Durapatite; Humans; Temporomandibular Joint; Temporomandibular Joint Disorders

2009
Inflammation and tissue damage in crystal deposition diseases.
    Current opinion in rheumatology, 2005, Volume: 17, Issue:3

    Topics: Calcium Phosphates; Calcium Pyrophosphate; Chondrocalcinosis; Disease Progression; Gout; Humans; Inflammation; Joints; Uric Acid

2005
Crystal deposition diseases: out of sight, out of mind.
    Current opinion in rheumatology, 2005, Volume: 17, Issue:3

    Topics: Calcium Pyrophosphate; Chondrocalcinosis; Chromium Compounds; Crystallization; Disease Progression; Humans; Osteoarthritis; Sulfates; Synovial Fluid; Uric Acid

2005
CPPD crystal deposition disease in patients with rheumatoid arthritis.
    Clinical rheumatology, 2006, Volume: 25, Issue:4

    Topics: Adult; Aged; Aged, 80 and over; Arthritis, Rheumatoid; Artificial Limbs; Calcium Pyrophosphate; Disease Progression; Female; Humans; Leg; Male; Middle Aged; Predictive Value of Tests; Retrospective Studies; Synovial Fluid

2006
[Diagnosis and treatment of calcium pyrophosphate crystal-induced arthropathy].
    Zeitschrift fur Rheumatologie, 2007, Volume: 66, Issue:7

    Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Calcium Pyrophosphate; Cartilage, Articular; Chondrocalcinosis; Colchicine; Diagnosis, Differential; Disease Progression; Glucocorticoids; Gout Suppressants; Humans; Injections, Intra-Articular; Interleukin-1beta; Methotrexate; Middle Aged; Risk Factors; Synovial Membrane

2007
Factors affecting radiographic progression of knee osteoarthritis.
    Annals of the rheumatic diseases, 1995, Volume: 54, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Analysis of Variance; Calcium Pyrophosphate; Disease Progression; Exercise Tolerance; Exudates and Transudates; Female; Follow-Up Studies; Hot Temperature; Humans; Knee Joint; Male; Middle Aged; Osteoarthritis; Prognosis; Prospective Studies; Radiography; Reproducibility of Results; Synovial Fluid

1995
Apatite cement containing antibiotics: efficacy in treating experimental osteomyelitis.
    Journal of orthopaedic science : official journal of the Japanese Orthopaedic Association, 1999, Volume: 4, Issue:5

    Topics: Administration, Topical; Animals; Anti-Bacterial Agents; Apatites; Bone Cements; Bone Marrow; Bone Transplantation; Calcium Phosphates; Curettage; Delayed-Action Preparations; Disease Models, Animal; Disease Progression; Drug Delivery Systems; Female; Gentamicins; Lactic Acid; Osteogenesis; Osteomyelitis; Polyesters; Polymers; Rabbits; Staphylococcal Infections; Therapeutic Irrigation; Tibia

1999